Laws designed to encourage companies to do more in terms of testing and developing medicines for children are allowing companies retain the market for theres drugs without facing competition for a longer period of time. As a result, the treatments cost a lot more.
National polls identify high drug prices as Americans’ No. 1 health care complaint. But these behind-the-scenes partnerships between the pharmaceutical industry and rare disease advocacy groups may work against lowering the price of high-price drugs.
Researchers in the U.S. and around the world, including here at the University of Washington’s Institute for Protein Design, are developing the tools needed to quickly and safely destroy nerve agents – both in storage facilities and in the human body.
A local environmental advocacy group last week launched a first-of-its kind monitoring project, installing air quality sensors in the densely packed neighborhoods near this city’s port to give the people who live and work there on-the-ground readings of pollutants that can seriously injure their health.
The Allen Institute for Cell Science today launched a website were anyone can explore the 3-D structure of human stem cells online. The site, called the Allen Cell Explorer, will provide scientists a new way to study how diverse human stem cells are structured and organized, which should provide insight into what makes human cells healthy and what […]
By Jordana Bell, Senior Lecturer, King’s College London; Jeffrey Craig, Principal Research Fellow, Murdoch Childrens Research Institute, and Juan Castillo-Fernandez, PhD candidate, King’s College London The rate of IVF births has risen dramatically in recent years as fertility rates continue to fall worldwide. To date, over 5m babies have been born with the help of […]
By Michelle Andrews Kaiser Health News Women whose health insurance covered in-vitro fertilization were more likely to repeat the procedure if necessary, boosting their likelihood of having a baby, compared with women who had to pay out-of-pocket for the pricey reproductive procedure, a new study found. The study, published this week in JAMA, analyzed the probability that […]
By Bruce Horovitz and Julie Appleby Kaiser Health News Laura Ries was moved to action when she saw a TV commercial that portrayed a woman enjoying time with her grandchildren after taking Lyrica, a prescription medication for diabetic nerve pain. Ries’ elderly mother suffered from just that problem. “The ad showed someone who was enjoying […]
By Liz Szabo Kaiser Health News WASHINGTON — For the first time, research shows that a pricey new medication called Repatha not only dramatically lowers LDL cholesterol, the “bad cholesterol,” it also reduces patients’ risk of dying or being hospitalized. Repatha, a man-made antibody also known as evolocumab, cut the combined risk of heart attack, […]
By Carmen Heredia Rodriguez Kaiser Health News An experimental treatment — which blinded three women after stem cells from abdominal fat were injected into their eyes — was advertised on a government-run clinical trial website but lacked proper safeguards, researchers reported Wednesday. The report in the New England Journal of Medicine notes that the procedures were […]